Literature DB >> 25195599

Antitumor activity of miR-1280 in melanoma by regulation of Src.

Vera Sun1, Wen B Zhou1, Mehdi Nosrati1, Shahana Majid2, Suresh Thummala1, David de Semir1, Vladimir Bezrookove1, Sebastien de Feraudy1, Liane Chun1, Dirk Schadendorf3, Robert Debs1, Mohammed Kashani-Sabet1, Altaf A Dar1.   

Abstract

MicroRNAs (miRNAs) play a key role in cancer progression by coordinately repressing target genes involved in cell proliferation, migration, and invasion. miRNAs regulate gene expression by repressing translation or directing sequence-specific degradation of complementary mRNA. Here, we report that expression of miR-1280 is significantly suppressed in human melanoma specimens when compared with nevi, and in human melanoma cell lines when compared with cultured normal human melanocytes. The proto-oncogene Src was identified as a target of miR-1280 action. Levels of Src expression were significantly higher in melanoma samples and cell lines than in nevi and normal melanocytes. miR-1280 overexpression significantly suppressed the luciferase activity of reporter plasmids containing the full-length 3' untranslated region of Src. miR-1280-mediated suppression of Src led to substantial decreases in melanoma cell proliferation, cell cycle progression, invasion, as well as induced melanoma cell apoptosis. The effects of miR-1280 overexpression on melanoma cell proliferation and growth were reversed by Src overexpression. Intratumoral delivery of miR-1280 significantly suppressed melanoma cell growth in vivo. Our results demonstrate a novel role for miR-1280 as a tumor suppressor in melanoma, identify the Src signaling pathway as a target of miR-1280 action, and suggest a potential therapeutic role for miR-1280 in melanoma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25195599      PMCID: PMC4426799          DOI: 10.1038/mt.2014.176

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  41 in total

Review 1.  MicroRNAs: small RNAs with a big role in gene regulation.

Authors:  Lin He; Gregory J Hannon
Journal:  Nat Rev Genet       Date:  2004-07       Impact factor: 53.242

2.  High response rate after intratumoral treatment with interleukin-2: results from a phase 2 study in 51 patients with metastasized melanoma.

Authors:  Benjamin Weide; Evelyna Derhovanessian; Annette Pflugfelder; Thomas K Eigentler; Peter Radny; Henning Zelba; Claudia Pföhler; Graham Pawelec; Claus Garbe
Journal:  Cancer       Date:  2010-09-01       Impact factor: 6.860

3.  OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma.

Authors:  Pedro P Medina; Mona Nolde; Frank J Slack
Journal:  Nature       Date:  2010-08-08       Impact factor: 49.962

Review 4.  MicroRNA-mediated control in the skin.

Authors:  R Yi; E Fuchs
Journal:  Cell Death Differ       Date:  2009-07-17       Impact factor: 15.828

Review 5.  Src kinases as therapeutic targets for cancer.

Authors:  Lori C Kim; Lanxi Song; Eric B Haura
Journal:  Nat Rev Clin Oncol       Date:  2009-10       Impact factor: 66.675

6.  Src activation in melanoma and Src inhibitors as therapeutic agents in melanoma.

Authors:  Jade Homsi; Christopher L Cubitt; Shumin Zhang; Pamela N Munster; Hua Yu; Daniel M Sullivan; Richard Jove; Jane L Messina; Adil I Daud
Journal:  Melanoma Res       Date:  2009-06       Impact factor: 3.599

7.  Inhibition of Src family kinases with dasatinib blocks migration and invasion of human melanoma cells.

Authors:  Ralf Buettner; Tania Mesa; Adina Vultur; Frank Lee; Richard Jove
Journal:  Mol Cancer Res       Date:  2008-11       Impact factor: 5.852

Review 8.  The role of Src in solid tumors.

Authors:  Deric L Wheeler; Mari Iida; Emily F Dunn
Journal:  Oncologist       Date:  2009-07-06

9.  Local and distant immunity induced by intralesional vaccination with an oncolytic herpes virus encoding GM-CSF in patients with stage IIIc and IV melanoma.

Authors:  Howard L Kaufman; Dae Won Kim; Gail DeRaffele; Josephine Mitcham; Rob S Coffin; Seunghee Kim-Schulze
Journal:  Ann Surg Oncol       Date:  2010-03       Impact factor: 5.344

10.  Elevated c-Src and c-Yes expression in malignant skin cancers.

Authors:  Jang Hyun Lee; Jae-Kyung Pyon; Dong Wook Kim; Sang Han Lee; Hae Seon Nam; Chul Han Kim; Sang Gue Kang; Yoon Jin Lee; Mi Youn Park; Dong Jun Jeong; Moon Kyun Cho
Journal:  J Exp Clin Cancer Res       Date:  2010-08-27
View more
  8 in total

1.  Naringin suppresses the metabolism of A375 cells by inhibiting the phosphorylation of c-Src.

Authors:  Bingyu Guo; Yu Zhang; Qiang Hui; Hongyi Wang; Kai Tao
Journal:  Tumour Biol       Date:  2015-10-17

2.  MicroRNA-365 inhibits growth, invasion and metastasis of malignant melanoma by targeting NRP1 expression.

Authors:  Juanjuan Bai; Zhongling Zhang; Xing Li; Huifan Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

Review 3.  The roles of microRNAs related with progression and metastasis in human cancers.

Authors:  Hai-Ting Liu; Peng Gao
Journal:  Tumour Biol       Date:  2016-10-06

4.  Inhibition of S-Adenosylmethionine-Dependent Methyltransferase Attenuates TGFβ1-Induced EMT and Metastasis in Pancreatic Cancer: Putative Roles of miR-663a and miR-4787-5p.

Authors:  Hardik R Mody; Sau Wai Hung; Mohammad AlSaggar; Jazmine Griffin; Rajgopal Govindarajan
Journal:  Mol Cancer Res       Date:  2016-09-13       Impact factor: 5.852

Review 5.  Small molecules targeting microRNA for cancer therapy: Promises and obstacles.

Authors:  Di Wen; Michael Danquah; Amit Kumar Chaudhary; Ram I Mahato
Journal:  J Control Release       Date:  2015-08-06       Impact factor: 9.776

Review 6.  MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets.

Authors:  Soudeh Ghafouri-Fard; Mahdi Gholipour; Mohammad Taheri
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

7.  Interleukin-8 is a key mediator of FKBP51-induced melanoma growth, angiogenesis and metastasis.

Authors:  S K Srivastava; A Bhardwaj; S Arora; N Tyagi; A P Singh; J E Carter; J G Scammell; Ø Fodstad; S Singh
Journal:  Br J Cancer       Date:  2015-05-05       Impact factor: 7.640

8.  The full recovery of mice (Mus Musculus C57BL/6 strain) from virus-induced sarcoma after treatment with a complex of DDMC delivery system and sncRNAs.

Authors:  Oxana V Klimenko; Alexey Sidorov
Journal:  Noncoding RNA Res       Date:  2019-03-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.